Differing Virulence of Healthy Skin Commensals in Mouse Models of Infection

Introduction: As therapies for atopic dermatitis (AD) based on live biotherapeutic products (LBP) are developed, the potential displacement of biotherapeutic strains, and species to mucosal sites where they are not naturally found is of investigative interest. However, formal assessment of the toxic...

Full description

Bibliographic Details
Published in:	Frontiers in Cellular and Infection Microbiology
Main Authors:	Ian A. Myles, Ian N. Moore, Carlo R. Castillo, Sandip K. Datta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-01-01
Subjects:	microbiome Roseomonas mucosa Staphylococcus biotherapeutic atopic dermatis
Online Access:	https://www.frontiersin.org/article/10.3389/fcimb.2018.00451/full

Similar Items

Assessing microbial manipulation and environmental pollutants in the pathogenesis of psoriasis
by: Portia Gough, et al.
Published: (2022-12-01)

DETERMINATION SOME IMMUNOLOGICAL AND HISTOPATHOLOGICAL PARAMETERS RELATED WITH ROSEOMONAS MUCOSA AND ITS PIGMENT IN PHARMACEUTICAL FORMULAS.
by: Teeba G. Albadri, et al.
Published: (2023-06-01)

Cellulitis caused by Roseomonas mucosa in a child: a case report
by: Yuki Matsuhisa, et al.
Published: (2023-12-01)

Roseomonas Mucosa Bacteremia in an Immunocompetent Child
by: Sonu Kumari Agrawal, et al.
Published: (2024-01-01)

Case Report: A rare case of community-acquired Roseomonas mucosa sepsis that presented with persistently normal host-response biomarkers
by: Xiaomei Xu, et al.
Published: (2025-04-01)

MOLECULAR IDENTIFICATION OF ROSEOMONAS MUCOSA AND DETERMINATION THE SOME OF ITS VIRULENCE FACTORS
by: Teeba G. Albadri, et al.
Published: (2023-04-01)

Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab
by: Caroline Meyer Olesen, et al.
Published: (2021-07-01)

A case report on bullous cellulitis due to Roseomonas gilardii infection
by: Wan Nor Aina Ar-Mardiyah Wan Jeffery, et al.
Published: (2022-03-01)

The Role of Skin Dysbiosis and Quorum Sensing in Atopic Dermatitis
by: Hiroki Okamoto, et al.
Published: (2025-07-01)

Septic arthritis and osteomyelitis due to Roseomonas; Case report and review of soft tissue, joint and bone infection
by: Minyoung Her
Published: (2023-01-01)

Microbiological assessment of the effectiveness of standard therapy in atopic dermatitis
by: Olga Yu. Olisova, et al.
Published: (2023-07-01)

ASSESSMENT OF THE STATE OF THE SKIN MICROBIOME OF PATIENTS WITH ALLERGODERMATOSES
by: J. B. Mullakhanov
Published: (2020-12-01)

Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii
by: Rebeca Martín, et al.
Published: (2018-03-01)

Staphylococcus aureus colonizing the skin microbiota of adults with severe atopic dermatitis exhibits genomic diversity and convergence in biofilm traits
by: Francesca Sivori, et al.
Published: (2024-12-01)

Biodegradation of Tetracycline Antibiotics by the Yeast Strain <i>Cutaneotrichosporon dermatis</i> M503
by: Hao Tan, et al.
Published: (2022-03-01)

Postbiotics and their biotherapeutic potential for chronic disease and their feature perspective: a review
by: Zerihun Asefa, et al.
Published: (2025-03-01)

Improvement of Indigofera zollingeriana Production and Methionine Content through Inoculation of Nitrogen-Fixing Bacteria
by: P. S. Hutapea, et al.
Published: (2018-04-01)

Changes in Lesional and Non-lesional Skin Microbiome During Treatment of Atopic Dermatitis
by: Sunyoung Kwon, et al.
Published: (2018-12-01)

A Calm, Dispassionate Look at Skin Microbiota in Atopic Dermatitis: An Integrative Literature Review
by: Pengjie Wan, et al.
Published: (2020-01-01)

Editorial: Next-Generation Probiotics: From Commensal Bacteria to Novel Drugs and Food Supplements
by: Philippe Langella, et al.
Published: (2019-08-01)

Microbiota-directed biotherapeutics: considerations for quality and functional assessment
by: Emily Ef Fekete, et al.
Published: (2023-12-01)

A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent <i>Clostridioides difficile</i> Infection
by: Yifan Wang, et al.
Published: (2024-05-01)

Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
by: Nagarakanti S, et al.
Published: (2023-05-01)

Innovations in Therapeutic Improvement of the Cutaneous Microbiome in Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics
by: Jason Goldsmith, et al.
Published: (2024-12-01)

Dynamic observation of upper airways colonization in a cystic fibrosis patient infected with <i>Roseomonas aerofrigidens</i> under targeted therapy
by: E. D. Dzhovmardova, et al.
Published: (2025-07-01)

Clinical application of live biotherapeutic products in infectious diseases
by: Bhagyashri D. Navalkele, et al.
Published: (2024-07-01)

Systems and synthetic biology-driven engineering of live bacterial therapeutics
by: Kangsan Kim, et al.
Published: (2023-10-01)

Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics
by: Tom Zaplana, et al.
Published: (2024-01-01)

A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls
by: Christopher J. Barnes, et al.
Published: (2023-09-01)

Management and Prevention of Atopic Dermatitis Infectious Complications in Children
by: Roman V. Epishev, et al.
Published: (2023-11-01)

Mechanisms of Development and Variants of Therapeutic Management of Steroid Resistance in Patients with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

Combined metagenomic- and culture-based approaches to investigate bacterial strain–level associations with medication-controlled mild-moderate atopic dermatitis
by: Nicole M. Lane Starr, PhD, et al.
Published: (2024-08-01)

Staphylococcus aureus colonization on antecubital non-exacerbated atopic dermatitis patient compared to healthy children
by: Nur Khamidah, et al.
Published: (2019-03-01)

The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation
by: Chiara Amoroso, et al.
Published: (2020-05-01)

Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
by: Naoka Umemoto, et al.
Published: (2024-01-01)

Tunable control of B. infantis abundance and gut metabolites by co-administration of human milk oligosaccharides
by: Abigail L. Reens, et al.
Published: (2024-12-01)

Disorders of the skin microbiome in atopic dermatitis and psoriasis
by: Marina Yu. Nikolaeva, et al.
Published: (2021-12-01)

In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of <i>Parabacteroides distasonis</i> Strains Alleviating TNBS-Induced Colitis in Mice
by: Bernardo Cuffaro, et al.
Published: (2020-09-01)

Altered Maturation of the Skin Microbiome in Infants with Atopic Dermatitis
by: Caroline M. Olesen, et al.
Published: (2022-11-01)